In a new Everyday Health article by Korin Miller, I joined Lisa Moskovitz, RD, CEO of NY Nutrition Group, and Scott Keatley, RD, co-owner of Keatley Medical Nutrition Therapy, to examine the diets claims, potential benefits, and some significant red flags
doi: 10.1503/cmaj.050051
Continuous outcomes were computed with mean differences (MD) and 95% confidence intervals (CI) with random-effect models
Mounjaro and Zepbound have positioned Lilly as a commercial force, while retatrutide and orforglipron give the company strong next-generation optionality
Blood tests during this phase may show elevated fasting insulin with only marginally elevated glucose
The findings were made by researchers at the University of Colorado Anschutz Medical Campus, who observed unusual changes in brain connectivity while studying adolescents and young women taking GLP-1 medications for a hormonal condition affecting the ovaries, The Washington Post reported
